{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:55:14Z","timestamp":1785542114334,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007915","name":"Baylor College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1053\/j.ajkd.2019.07.015","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T23:10:04Z","timestamp":1570576204000},"page":"351-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis"],"prefix":"10.1053","volume":"75","author":[{"given":"Chandan","family":"Vangala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Montez-Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankar D.","family":"Navaneethan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang C.","family":"Winkelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.ajkd.2019.07.015_bib1","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1681\/ASN.2012090916","article-title":"Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients","volume":"24","author":"Beaubrun","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.07.015_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0272-6386(04)00958-8","article-title":"Increased risk of mortality associated with hip fracture in the dialysis population","volume":"44","author":"Mittalhenkle","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2019.07.015_bib3","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2215\/CJN.10901012","article-title":"Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States","volume":"8","author":"Nair","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.07.015_bib4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1053\/j.ajkd.2013.02.368","article-title":"Trends in hip fracture rates in US hemodialysis patients, 1993-2010","volume":"62","author":"Arneson","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"3 suppl 1","key":"10.1053\/j.ajkd.2019.07.015_bib5","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US Renal Data System 2018 Annual Data Report: epidemiology of kidney disease in the United States","volume":"73","author":"Saran","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"19","key":"10.1053\/j.ajkd.2019.07.015_bib6","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1001\/jama.2017.17131","article-title":"Effect of sertraline on depressive symptoms in patients with chronic kidney disease without dialysis dependence: the CAST randomized clinical trial","volume":"318","author":"Hedayati","year":"2017","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2019.07.015_bib7","first-page":"CD004541","article-title":"Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis","volume":"5","author":"Palmer","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1053\/j.ajkd.2019.07.015_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/M18-2229","article-title":"Comparative efficacy of therapies for treatment of depression for patients undergoing maintenance hemodialysis: a randomized clinical trial","volume":"170","author":"Mehrotra","year":"2019","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1053\/j.ajkd.2019.07.015_bib9","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/gps.4974","article-title":"Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: a systematic review and meta-analysis","volume":"33","author":"Khanassov","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.015_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00198-012-2015-9","article-title":"Relationship between use of antidepressants and risk of\u00a0fractures: a meta-analysis","volume":"24","author":"Rabenda","year":"2013","journal-title":"Osteoporos Int"},{"issue":"9112","key":"10.1053\/j.ajkd.2019.07.015_bib11","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(97)09528-7","article-title":"Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people","volume":"351","author":"Liu","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1053\/j.ajkd.2019.07.015_bib12","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jbmr.1554","article-title":"Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis","volume":"27","author":"Eom","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"issue":"2","key":"10.1053\/j.ajkd.2019.07.015_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00223-018-0398-0","article-title":"Selective serotonin reuptake inhibitors (SSRIs) and markers of bone turnover in men","volume":"103","author":"Williams","year":"2018","journal-title":"Calc Tissue Int"},{"issue":"3","key":"10.1053\/j.ajkd.2019.07.015_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.eurpsy.2010.10.006","article-title":"The adverse skeletal effects of selective serotonin reuptake inhibitors","volume":"27","author":"Tsapakis","year":"2012","journal-title":"Eur Psychiatry"},{"issue":"8","key":"10.1053\/j.ajkd.2019.07.015_bib15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jash.2018.06.002","article-title":"The association between antidepressant use and orthostatic hypotension in older people: a matched cohort study","volume":"12","author":"Briggs","year":"2018","journal-title":"J\u00a0Am Soc Hypertens"},{"issue":"10","key":"10.1053\/j.ajkd.2019.07.015_bib16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jagp.2014.11.004","article-title":"Cause or effect? Selective serotonin reuptake inhibitors and falls in older adults: a systematic review","volume":"23","author":"Gebara","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"issue":"7","key":"10.1053\/j.ajkd.2019.07.015_bib17","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2215\/CJN.10141013","article-title":"Addressing missing data in clinical studies of kidney diseases","volume":"9","author":"Montez-Rath","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2019.07.015_bib18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/10629360600810434","article-title":"Fully conditional specification in multivariate imputation","volume":"76","author":"Van Buuren","year":"2006","journal-title":"J\u00a0Stat Comput Simul"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.015_bib19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ekir.2016.09.005","article-title":"Depression in chronic kidney disease and end-stage renal disease: similarities and differences in diagnosis, epidemiology, and management","volume":"2","author":"Shirazian","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.015_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2190\/WQ33-M54T-XN7L-V8MX","article-title":"Fluoxetine in depressed patients on dialysis","volume":"27","author":"Blumenfield","year":"1997","journal-title":"Int J Psychiatry Med"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.015_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000441-200501000-00001","article-title":"Treatment of depression and effect of antidepression treatment on nutritional status in chronic hemodialysis patients","volume":"329","author":"Koo","year":"2005","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.015_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1681\/ASN.2012111134","article-title":"Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis","volume":"25","author":"Cukor","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.015_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.23876\/j.krcp.2018.37.1.77","article-title":"Effectiveness of group cognitive behavioral therapy with mindfulness in end-stage renal disease hemodialysis patients","volume":"37","author":"Sohn","year":"2018","journal-title":"Kidney Res Clin Pract"},{"issue":"4","key":"10.1053\/j.ajkd.2019.07.015_bib24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jamda.2016.12.003","article-title":"Use of selective serotonin reuptake inhibitors and risk of hip fracture in the elderly: a case-control study in Taiwan","volume":"18","author":"Hung","year":"2017","journal-title":"J\u00a0Am Med Direct Assoc"},{"issue":"4","key":"10.1053\/j.ajkd.2019.07.015_bib25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/JCP.0b013e31817d5943","article-title":"Fracture risk from psychotropic medications: a population-based analysis","volume":"28","author":"Bolton","year":"2008","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"2","key":"10.1053\/j.ajkd.2019.07.015_bib26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archinte.167.2.188","article-title":"Effect of selective serotonin reuptake inhibitors on the risk of fracture","volume":"167","author":"Richards","year":"2007","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2019.07.015_bib27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00198-005-0065-y","article-title":"Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture","volume":"17","author":"Vestergaard","year":"2006","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1053\/j.ajkd.2019.07.015_bib28","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1007\/s00198-016-3667-7","article-title":"Patterns of selective serotonin reuptake inhibitor use and risk of falls and fractures in community-dwelling elderly people: the Three-City cohort","volume":"27","author":"Carriere","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1053\/j.ajkd.2019.07.015_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-3-319-66653-2_3","article-title":"Regulation of bone metabolism by serotonin","volume":"1033","author":"Lavoie","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"10.1053\/j.ajkd.2019.07.015_bib30","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1093\/ndt\/gfs295","article-title":"Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP)","volume":"27","author":"Nagler","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1053\/j.ajkd.2019.07.015_bib31","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jagp.2017.08.014","article-title":"Association between antidepressants and fall-related injuries among long-term care residents","volume":"25","author":"Macri","year":"2017","journal-title":"Am J Geriatr Psychiatry"},{"issue":"9","key":"10.1053\/j.ajkd.2019.07.015_bib32","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/jbmr.3443","article-title":"High serum serotonin predicts increased risk for hip fracture and nonvertebral osteoporotic fractures: the MrOS Sweden Study","volume":"33","author":"Kristjansdottir","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"issue":"6","key":"10.1053\/j.ajkd.2019.07.015_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/WNF.0b013e31823337d1","article-title":"Unraveling the association between SSRI use and falls: an experimental study of risk factors for accidental falls in long-term paroxetine users","volume":"34","author":"Hegeman","year":"2011","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"10.1053\/j.ajkd.2019.07.015_bib34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S8756-3282(01)00593-2","article-title":"Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake","volume":"29","author":"Bliziotes","year":"2001","journal-title":"Bone"},{"issue":"31","key":"10.1053\/j.ajkd.2019.07.015_bib35","doi-asserted-by":"crossref","first-page":"28961","DOI":"10.1074\/jbc.M101824200","article-title":"Expression of serotonin receptors in bone","volume":"276","author":"Westbroek","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"9","key":"10.1053\/j.ajkd.2019.07.015_bib36","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1359\/JBMR.040606","article-title":"Serotonin regulates osteoclast differentiation through its transporter","volume":"19","author":"Battaglino","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.015_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/cn300127h","article-title":"Chronic SSRI treatment exacerbates serotonin deficiency in humanized Tph2 mutant mice","volume":"4","author":"Siesser","year":"2013","journal-title":"ACS Chem Neurosci"},{"issue":"18","key":"10.1053\/j.ajkd.2019.07.015_bib38","doi-asserted-by":"crossref","first-page":"Pl187","DOI":"10.1016\/0024-3205(93)90116-K","article-title":"Time course of brain serotonin metabolism after cessation of long-term fluoxetine treatment in the rat","volume":"52","author":"Trouvin","year":"1993","journal-title":"Life Sci"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.015_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1476-5381.1993.tb13817.x","article-title":"The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain","volume":"110","author":"Caccia","year":"1993","journal-title":"Br J Pharmacol"},{"issue":"1-2","key":"10.1053\/j.ajkd.2019.07.015_bib40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2011.08.013","article-title":"Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs","volume":"136","author":"Bismuth-Evenzal","year":"2012","journal-title":"J\u00a0Affect Disord"},{"issue":"1","key":"10.1053\/j.ajkd.2019.07.015_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s002130050924","article-title":"Plasma serotonin level after 1 day of fluoxetine treatment: a biological predictor for antidepressant response?","volume":"143","author":"Alvarez","year":"1999","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1053\/j.ajkd.2019.07.015_bib42","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","article-title":"Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum","volume":"135","author":"Yadav","year":"2008","journal-title":"Cell"},{"key":"10.1053\/j.ajkd.2019.07.015_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2017.08.004","article-title":"The impact of peripheral serotonin on leptin-brain serotonin axis, bone metabolism and strength in growing rats with experimental chronic kidney disease","volume":"105","author":"Pawlak","year":"2017","journal-title":"Bone"},{"issue":"10","key":"10.1053\/j.ajkd.2019.07.015_bib44","article-title":"The associations of serum serotonin with bone traits are age- and gender-specific","volume":"9","author":"Wang","year":"2014","journal-title":"PloS One"},{"key":"10.1053\/j.ajkd.2019.07.015_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2017.02.001","article-title":"The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line","volume":"41","author":"Hansen","year":"2017","journal-title":"Toxicol In\u00a0Vitro"},{"issue":"4","key":"10.1053\/j.ajkd.2019.07.015_bib46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/JCP.0b013e31817e6f80","article-title":"Evaluation of endocrine profile and hypothalamic-pituitary-testis axis in selective serotonin reuptake inhibitor-induced male sexual dysfunction","volume":"28","author":"Safarinejad","year":"2008","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"3","key":"10.1053\/j.ajkd.2019.07.015_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ki.2011.358","article-title":"A\u00a0practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease","volume":"81","author":"Hedayati","year":"2012","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2019.07.015_bib48","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ki.2013.399","article-title":"Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport","volume":"85","author":"Yeung","year":"2014","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619309448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619309448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:23:59Z","timestamp":1759461839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638619309448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0272638619309448"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.07.015","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use.","name":"copyright","label":"Copyright"}]}}